1. Davies L E, Spiers G, Kingston A, et al. Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews. JAMDA. 2019;0:1-7.
https://doi.org/10.1016/j.jamda.2019.10.022
2. Chang TI, Park H, Kim DW, et al. Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study. Scientifc Reports. 2020;10:18964 DOI: https://doi.org/10.1038/s41598-020-75888-8
3. Alsuwaidan A, Almedlej N, Alsabti S, et al. A Comprehensive Overview of Polypharmacy in Elderly Patients in Saudi Arabia. Geriatrics. 2019;4(36): 1-10
https://doi.org/10.3390/geriatrics4020036
4. Kim J, Parish AL. Polypharmacy and Medication Management in Older Adults. Nurs Clin North Am. 2017 Sep;52(3):457-468. doi: 10.1016/j.cnur.2017.04.007. PMID: 28779826.
5. Vrettos I, Voukelatou P, Katsoras A, et al. Diseases Linked to Polypharmacy in Elderly Patients. Hindawi Current Gerontology and Geriatrics Research. 2017;1-5. https://doi.org/10.1155/2017/4276047
6. Tierney Anne DH, Scarbrough C, Carroll D. Polypharmacy: Evaluating Risks and Deprescribing. American Family Physician. 2019;100(1):32-38
7. Schenker Y, Park S Y, Jeong K, et al. Associations Between Polypharmacy, Symptom Burden, and Quality of Life in Patients with Advanced, Life-Limiting Illness. J Gen Intern Med. 2019;0(0):1-8. DOI: 10.1007/s11606-019-04837-7
8. Schottker B, Saum KW, Muhlack DC, et al. Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication. Eur J Clin Pharmacol.2017;0:1-8 DOI 10.1007/s00228-017-2266-7
9. Sahne BS. An Overview of Polypharmacy in Geriatric Patients, in: challenges in elder care. IntechOpen.2016;0: 69-80 http://dx.doi.org/10.5772/64793
10. Leelakanok N, Holcombe AL, Lund BC, Gu X, Schweizer ML. Association between polypharmacy and death: A systematic review and meta-analysis. J Am Pharm Assoc (2003). 2017 Nov-Dec;57(6):729-738.e10. doi: 10.1016/j.japh.2017.06.002. Epub 2017 Aug 5. PMID: 28784299.
11. Al-Musawe L, Martins AP, Raposo JF, Torre C. The association between polypharmacy and adverse health consequences in elderly type 2 diabetes mellitus patients; a systematic review and meta-analysis. Diabetes Res Clin Pract. 2019 Sep;155:107804. doi: 10.1016/j.diabres.2019.107804. Epub 2019 Jul 31. PMID: 31376400.
12. Rankin A, Cadogan CA, Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database of Systematic Reviews. 2018;9:Art No.CD008165.DOI: 10.1002/14651858.CD008165.pub4
13. Earl TR, Katapodis ND, Schneiderman SR, et al. Using Deprescribing Practices and the Screening Tool of Older Persons’ Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults. J Patient Saf. 2020;16(3): S23–S35 doi: 10.1097/PTS.0000000000000747
14. The American Geriatrics Society. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67(4):674-694 doi: 10.1111/jgs.15767